[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337318-105":59,"doc-detail-337318-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","germline-testing-of-iranian-families-suspected-of-lynch-syndrome-molecular-characterization-and-current-surveillance-of-families-with-pathogenic-variants-in-msh2-msh6-and-pms2","Germline testing of Iranian families suspected of Lynch syndrome - molecular characterization and current surveillance of families with pathogenic variants in MSH2, MSH6, and PMS2","","Lynch syndrome accounts for 3–5% of colorectal and endometrial cancer cases, yet carriers in the Middle East have been underdiagnosed due to suboptimal management. The study evaluates probands from 24 unrelated Iranian families using microsatellite instability analysis or immunohistochemistry, multigene panel testing, copy number variation detection, and multiplex ligation-dependent probe amplification. Pathogenic variants were found in 5 patients (21%), predominantly in MSH2, and cascade screening informed family surveillance. The authors also assess feasibility of telematic blood-sample coordination and the impact of insurance coverage on access to next-generation sequencing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/germline-testing-of-iranian-families-suspected-of-lynch-syndrome-molecular-characterization-and-current-surveillance-of-families-with-pathogenic-variants-in-msh2-msh6-and-pms2/337318/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/germline-testing-of-iranian-families-suspected-of-lynch-syndrome-molecular-characterization-and-current-surveillance-of-families-with-pathogenic-variants-in-msh2-msh6-and-pms2/337318.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this germline testing study in Iranian families?","Question",{"text":112,"@type":113},"To characterize pathogenic variants in families suspected of Lynch syndrome and to review current surveillance and family cascade testing practices.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genetic tests were used for probands from the 24 Iranian families?",{"text":117,"@type":113},"Microsatellite instability analysis or immunohistochemistry, multigene panel testing, copy number variation detection, and multiplex ligation-dependent probe amplification.",{"name":119,"@type":110,"acceptedAnswer":120},"What proportion of patients had pathogenic variants, and where were they found?",{"text":121,"@type":113},"Pathogenic variants were identified in five patients (21%), with three in MSH2, one in MSH6, and one in PMS2.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337318,1790545683,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Research  \npaper  \n349  \nGermline testing of Iranian families suspected of Lynch syndrome: molecular characterization and current surveillance of families with pathogenic variants in MSH2, MSH6, and PMS2  \nMohammad Sinaa,b, Shiva Zarinfamb, Silvia Clara Giliania,c,*, Pietro Luigi Polianid and Keivan Majidzadeh-Ab,*  \nLynch syndrome accounts for 3–5% of all colorectal and endometrial cancer cases, and suboptimal management of Lynch syndrome in the Middle East resulted in the underdiagnosis of mutation carriers. Probands from 24 unrelated Iranian families with a history of cancer(s) suggestive of Lynch syndrome underwent microsatellite instability analysis or immunohistochemistry, multigene panel testing, copy number variation detection, or multiplex ligation-dependent probe amplification. Pathogenic variants were identified in five patients (21%), including three in MSH2, one in MSH6, and one in PMS2. Microsatellite instability analysis showed the lengths of the CAT25 marker in tumor and normal samples were  \n149 and 148 bp, respectively. Among 21 family members with Lynch syndrome in the MSH2 gene, identified from the three families who previously underwent cascade screening, colorectal and endometrial cancers were the most frequent. While 66% of patients had insurance that included coverage for mutation carrier screening, only one insurance provider extended coverage for next-generation sequencing. Special attention to probands and telematic management of at-risk relatives to organize blood sample collection at their convenience enhanced cascade testing 20-fold per proband. In conclusion, the age of onset and segregation analysis indicated that PMS1 may not be a  \nBackground  \nGenetic defects play a role in predisposing individuals to up to 10% of malignancies, especially breast cancer and colorectal cancer (CRC). Lynch syndrome is the most common cause of hereditary colorectal syndrome, accounting for 3–5% of all CRCs. Patients with Lynch syndrome have a pathogenic variant in one of the mismatch repair (MMR) genes, MLH1 (OMIM\\# 120436), MSH2 (OMIM\\# 609309), MSH6 (OMIM\\# 600678), and PMS2 (OMIM\\# 600259), or deletions in the EPCAM (OMIM\\# 185535). Individuals with Lynch syndrome are prone to develop hereditary colorectal and endometrial neoplasms and a wide variety of other cancers, especially at young ages (Garutti et al., 2023).  \nThis is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \ncancer susceptibility gene, and the tumor spectrum in MSH2 pathogenic carriers is similar to Western countries. Collecting blood samples at patients’ convenience is a possible strategy to reduce the cost of identifying Lynch syndrome through cascade testing. The genetic analysis of patients for inherited cancers would optimize the current management of Lynch syndrome in Iran by omitting noncarriers from surveillance programs. European Journal of Cancer Prevention 34: 349–356 Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.  \nEuropean Journal of Cancer Prevention 2025, 34:349–356  \nKeywords: copy number variation analysis, DNA mismatch repair genes, genetic carrier screening, hereditary nonpolyposis, lynch syndrome surveillance, Lynch syndrome, PMS1  \naA. Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy, bGenetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran, c Section of Cytogenetics and Medical Genetics, Laboratory Department, ASST Spedali Civili and dPathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy  \nCorrespondence to Keivan Majidzadeh-A, MD,PhD, Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran 1517964311, Iran  \nTel: +98 ","cbCaiiLKYt4CO2Sz","https://ap.wps.com/l/cbCaiiLKYt4CO2Sz","pdf",722867,"English","# Background\n# Methods and genetic testing approach\n# Results: pathogenic variants and family screening\n# Surveillance strategy and insurance barriers\n# Conclusion","[{\"question\":\"What was the purpose of this germline testing study in Iranian families?\",\"answer\":\"To characterize pathogenic variants in families suspected of Lynch syndrome and to review current surveillance and family cascade testing practices.\"},{\"question\":\"Which genetic tests were used for probands from the 24 Iranian families?\",\"answer\":\"Microsatellite instability analysis or immunohistochemistry, multigene panel testing, copy number variation detection, and multiplex ligation-dependent probe amplification.\"},{\"question\":\"What proportion of patients had pathogenic variants, and where were they found?\",\"answer\":\"Pathogenic variants were identified in five patients (21%), with three in MSH2, one in MSH6, and one in PMS2.\"}]","Germline testing of Iranian families suspected of Lynch syndrome - molecular characterization and current surveillance of families with pathogenic variants in MSH2, MSH6, and PMS2 | PDF",1790018573,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b907da786c180ce3114084e11b8fada5.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25414d4b4286cc525b5d9984c2a3dba4.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f140cf8cdd72dd38d9e80a07d060e6b.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58eb6df6c068a856297f850395379be2.webp",980,1306]